News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Cathy Eng: Great Discussion on Rectal Cancer Session at ESMO GI25
Cathy Eng/X
Jul 4, 2025, 06:08

Cathy Eng: Great Discussion on Rectal Cancer Session at ESMO GI25

Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, posted on X:

“Thanks to all that showed up for our multi-D rectal cancer session at ESMO GI25.

GREAT discussion with Drs. Prager, Garcia-Aguilar and Vendrely.”

Further Reading: ESMO GI 2025 Highlights: PANOVA-3 Trial on TTFields + GnP in Unresectable LAPC

PANOVA-3

cancer Cathy Eng ESMO GI25 OncoDaily Oncology rectal cancer
Special Coverage
Blog Posts
Aug 15, 2025, 08:03
Carmen Monge-Montero: Sometimes the Bravest Thing You Can Do is Ask for Help
Science
Aug 15, 2025, 07:31
Bishoy Morris Faltas: Paired Plus-Minus Sequencing for Accurate Dual-Strand DNA Analysis
Stories
Aug 15, 2025, 06:47
Oya Gilbert's Story Highlights Urgent Need to Protect NIH Research Funding - AACR
Science
Aug 15, 2025, 06:42
Denis Panizza: How Tight Can SBRT Prostate Margins Go?
Science
Aug 15, 2025, 06:33
Immune Youth in Old Age: Mayo Clinic Uncovers the Double-Edged Sword - E. Shyam P. Reddy
Voices
Aug 15, 2025, 06:32
Where AI Meets the Future of Cancer Research - NFCR
Insight
Aug 15, 2025, 06:24
Harpreet Singh: New Era for ADCs in HER-2 + Metastatic Breast Cancer
Science
Aug 15, 2025, 06:18
Ramy Sedhom Shares Study on Inpatient Immunotherapy Outcomes
Science
Aug 15, 2025, 06:11
Miguel Bronchud: Can Use of Aprepitant During Chemotherapy Improve TNBC Outcomes?
Voices
Aug 15, 2025, 06:04
Lung Cancer in Africa: Gaps and Role of a Community of Practice - Move Against Cancer Africa
Voices
Aug 15, 2025, 05:56
Megan Burger: Huge Day for Cancer Care
Science
Aug 15, 2025, 05:47
Gerry Hanna Highlights a Study on Tumor Control and Immune Activation with Palliative Irradiation and ATR Inhibition